In this Cytovance® Biologics On Demand Webcast titled, Downstream Process Development: Strategies to Reduce Protein Aggregation,  viewers will review the aggregation problems frequently encountered in downstream purification of recombinant protein and monoclonal antibody products.

Dr. Brad Johnson will also discuss the causes of aggregation and strategies for reducing and removal of aggregates to acceptable levels during the development of processes to be used for cGMP production of therapeutic products.

View now